BIOMAT Database Logo BIOMAT Database Logo

Effects of combinations of interferon-beta ser and interferon-gamma on interferon-inducible proteins and on the cell cycle. 1990

J H Schiller, and M A Horisberger, and G Bittner, and J M Carlin, and B Storer, and G I Byrne, and J K Willson, and E C Borden
Department of Human Oncology, University of Wisconsin Clinical Cancer Center, Madison.

SKCO 1 human colon carcinoma cells have been shown to be synergistically inhibited in their growth by the combinations of alpha-interferon (IFN-alpha) or beta-interferon (IFN-beta ser) and gamma-interferon (IFN-gamma). To determine if a correlation could be established between this synergistic antiproliferative effect and a synergistic induction in IFN-inducible proteins, or a unique perturbation in the cell cycle, we studied the effects of IFN-beta ser and IFN-gamma, alone and in combination, on 2',5'-oligoadenylate (2-5A) synthetase, indoleamine-2,3-dioxygenase (IDO), a human analogue of the murine Mx protein (p78), and the phases of cell cycle. 2-5A synthetase was maximally induced after a 24-h exposure to both IFN-beta and IFN-gamma. A synergistic enhancement of 2-5A synthetase activity was observed only with low concentrations of each IFN (0.05 ng/ml). IDO activity was induced by IFN-gamma and the combination of IFN-beta ser and IFN-gamma, but not IFN-beta ser alone. The differences in IDO activity between IFN-gamma and the combination, however, were not statistically significant. The p78 protein was induced in a dose-dependent manner by IFN-alpha and IFN-beta ser. IFN-gamma enhanced the expression of p78 induction by IFN-alpha or IFN-beta ser, even at concentrations of IFN-gamma that did not induce the protein when administered as a single agent. The combination of IFN-alpha and IFN-beta ser, which results in an antagonistic antiproliferative effect, also resulted in an antagonistic induction of p78. No changes in the cell cycle were observed following exposure to IFN-beta ser, IFN-gamma, or the combination, and treatment with IFN-gamma did not inhibit the accumulation of cells in G2M caused by colchicine. Thus, the synergistic antiproliferative effect produced by IFN-beta ser and IFN-gamma in SKCO 1 cells could not be correlated with a synergistic enhancement in 2-5A synthetase or IDO activity, or with a perturbation in the cell cycle. In contrast, the combination of IFN-gamma and IFN-alpha or IFN-beta ser synergistically enhanced the expression of p78 protein in these cells.

UI MeSH Term Description Entries
D007370 Interferon Type I Interferon secreted by leukocytes, fibroblasts, or lymphoblasts in response to viruses or interferon inducers other than mitogens, antigens, or allo-antigens. They include alpha- and beta-interferons (INTERFERON-ALPHA and INTERFERON-BETA). Interferons Type I,Type I Interferon,Type I Interferons,Interferon, Type I,Interferons, Type I
D011994 Recombinant Proteins Proteins prepared by recombinant DNA technology. Biosynthetic Protein,Biosynthetic Proteins,DNA Recombinant Proteins,Recombinant Protein,Proteins, Biosynthetic,Proteins, Recombinant DNA,DNA Proteins, Recombinant,Protein, Biosynthetic,Protein, Recombinant,Proteins, DNA Recombinant,Proteins, Recombinant,Recombinant DNA Proteins,Recombinant Proteins, DNA
D012044 Regression Analysis Procedures for finding the mathematical function which best describes the relationship between a dependent variable and one or more independent variables. In linear regression (see LINEAR MODELS) the relationship is constrained to be a straight line and LEAST-SQUARES ANALYSIS is used to determine the best fit. In logistic regression (see LOGISTIC MODELS) the dependent variable is qualitative rather than continuously variable and LIKELIHOOD FUNCTIONS are used to find the best relationship. In multiple regression, the dependent variable is considered to depend on more than a single independent variable. Regression Diagnostics,Statistical Regression,Analysis, Regression,Analyses, Regression,Diagnostics, Regression,Regression Analyses,Regression, Statistical,Regressions, Statistical,Statistical Regressions
D002453 Cell Cycle The complex series of phenomena, occurring between the end of one CELL DIVISION and the end of the next, by which cellular material is duplicated and then divided between two daughter cells. The cell cycle includes INTERPHASE, which includes G0 PHASE; G1 PHASE; S PHASE; and G2 PHASE, and CELL DIVISION PHASE. Cell Division Cycle,Cell Cycles,Cell Division Cycles,Cycle, Cell,Cycle, Cell Division,Cycles, Cell,Cycles, Cell Division,Division Cycle, Cell,Division Cycles, Cell
D002455 Cell Division The fission of a CELL. It includes CYTOKINESIS, when the CYTOPLASM of a cell is divided, and CELL NUCLEUS DIVISION. M Phase,Cell Division Phase,Cell Divisions,Division Phase, Cell,Division, Cell,Divisions, Cell,M Phases,Phase, Cell Division,Phase, M,Phases, M
D003110 Colonic Neoplasms Tumors or cancer of the COLON. Cancer of Colon,Colon Adenocarcinoma,Colon Cancer,Cancer of the Colon,Colon Neoplasms,Colonic Cancer,Neoplasms, Colonic,Adenocarcinoma, Colon,Adenocarcinomas, Colon,Cancer, Colon,Cancer, Colonic,Cancers, Colon,Cancers, Colonic,Colon Adenocarcinomas,Colon Cancers,Colon Neoplasm,Colonic Cancers,Colonic Neoplasm,Neoplasm, Colon,Neoplasm, Colonic,Neoplasms, Colon
D004357 Drug Synergism The action of a drug in promoting or enhancing the effectiveness of another drug. Drug Potentiation,Drug Augmentation,Augmentation, Drug,Augmentations, Drug,Drug Augmentations,Drug Potentiations,Drug Synergisms,Potentiation, Drug,Potentiations, Drug,Synergism, Drug,Synergisms, Drug
D004790 Enzyme Induction An increase in the rate of synthesis of an enzyme due to the presence of an inducer which acts to derepress the gene responsible for enzyme synthesis. Induction, Enzyme
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000068556 Interferon beta-1a An interferon beta-1 subtype that has a methionine at position 1, a cysteine at position 17, and is glycosylated at position 80. It functions as an ANTI-VIRAL AGENT and IMMUNOMODULATOR and is used to manage the symptoms of RELAPSING-REMITTING MULTIPLE SCLEROSIS. Avonex,Avonex Pen,Interferon beta 1a,Rebif,beta 1a, Interferon,beta-1a, Interferon

Related Publications

J H Schiller, and M A Horisberger, and G Bittner, and J M Carlin, and B Storer, and G I Byrne, and J K Willson, and E C Borden
A direct comparison of biological response modulation and clinical side effects by interferon-beta ser, interferon-gamma, or the combination of interferons beta ser and gamma in humans.
October 1990, The Journal of clinical investigation,
J H Schiller, and M A Horisberger, and G Bittner, and J M Carlin, and B Storer, and G I Byrne, and J K Willson, and E C Borden
Effects of interferon beta ser and transforming growth factor beta on prostatic cell lines.
October 1991, The Journal of urology,
J H Schiller, and M A Horisberger, and G Bittner, and J M Carlin, and B Storer, and G I Byrne, and J K Willson, and E C Borden
Synergistic antiproliferative effects of human recombinant alpha 54- or beta ser-interferon with gamma-interferon on human cell lines of various histogenesis.
February 1986, Cancer research,
J H Schiller, and M A Horisberger, and G Bittner, and J M Carlin, and B Storer, and G I Byrne, and J K Willson, and E C Borden
Synthesis of interferon-inducible proteins is regulated differently by interferon-alpha and interferon-gamma.
April 1984, Virology,
J H Schiller, and M A Horisberger, and G Bittner, and J M Carlin, and B Storer, and G I Byrne, and J K Willson, and E C Borden
Interferon-gamma: pleiotropic effects on a rat pancreatic beta cell line.
July 1987, Molecular and cellular endocrinology,
J H Schiller, and M A Horisberger, and G Bittner, and J M Carlin, and B Storer, and G I Byrne, and J K Willson, and E C Borden
The interferon-inducible p200 family of proteins: a perspective on their roles in cell cycle regulation and differentiation.
January 2004, Blood cells, molecules & diseases,
J H Schiller, and M A Horisberger, and G Bittner, and J M Carlin, and B Storer, and G I Byrne, and J K Willson, and E C Borden
Effects of interferon-alpha on cell cycle regulatory proteins in leukemic cells.
June 2003, Leukemia & lymphoma,
J H Schiller, and M A Horisberger, and G Bittner, and J M Carlin, and B Storer, and G I Byrne, and J K Willson, and E C Borden
Absence of biological effects of orally administered interferon-beta ser.
December 1992, Journal of interferon research,
J H Schiller, and M A Horisberger, and G Bittner, and J M Carlin, and B Storer, and G I Byrne, and J K Willson, and E C Borden
Modulation of interferon receptor expression during combination beta ser-interferon and gamma-interferon treatment of human colon carcinoma cells.
January 1990, Cancer research,
J H Schiller, and M A Horisberger, and G Bittner, and J M Carlin, and B Storer, and G I Byrne, and J K Willson, and E C Borden
Biological and clinical effects of interferon-beta ser at two doses.
December 1990, Journal of interferon research,
Copied contents to your clipboard!